X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

Clinical trial NCT04389281 · RECRUITING

Trial details

NCT number: NCT04389281
Sponsor: Immunolight, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cancer

Start date: 2021-12-08
Primary completion: 2028-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.